Crossmark

Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology

Crossref DOI link: https://doi.org/10.1016/j.anpede.2023.10.011

Published Print: 2024-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Medrano López, Constancio

Centeno Malfaz, Fernando

Garcés Sánchez, María
Funding

Funding for this research was provided by:

AstraZeneca España
License Information

Text and Data Mining valid from 2024-02-01

Version of Record valid from 2024-01-11
More Information

This article is maintained by: Elsevier

Article Title: Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology

Journal Title: Anales de Pediatría (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.anpede.2023.10.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.anpedi.2023.10.006

Content Type: simple-article

Copyright: © 2023 Asociación Española de Pediatría. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below